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Enforced Expression of Bcl-2 in Monocytes
Rescues Macrophages and Partially Reverses
Osteopetrosis in op/op Mice
Eric Lagasse and Irving L. Weissman determined partly by induction of its receptor during or
after commitment to the monocytic lineage (Tushinski etDepartment of Pathology and Developmental Biology
Stanford University School of Medicine al., 1982), and partly by down-modulation of the receptor
during early granulocytic differentiation (McArthur et al.,Stanford, California 94305
1994). The ability to respond to M-CSF is an early event
in monocyte commitment and has a role in macrophage
maturation. Osteopetrotic op/op mice (Marks and Lane,
Summary 1976), which have an autosomal recessive inactivating
mutation in the M-CSF gene (Yoshida et al., 1990), show
Osteopetrotic (op/op) mice lack functional M-CSF and impaired development of monocytic cells and a defi-
have depressed levels of macrophages and osteo- ciency of both macrophage populations and osteoclasts
clasts. We prepared transgenic mice (hMRP8bcl-2) (Wiktor-Jedrzejczak et al., 1982, 1990).
that express human Bcl-2 in monocytes. In vitro The precise role of M-CSF in monocyte commitment
hMRP8bcl-2 monocytes do not undergo apoptosis in is controversial. Two general models for M-CSF control
the absence of serum and M-CSF, while op/op and of monocyte differentiation can be proposed, based on
wild-typemonocytesdie. TheseBcl-2-expressing mono- early studies of spleen and bone marrow multilineage
cytes spontaneously undergo macrophage differenti- colony±forming cells. In an adaptation of the instructive
ation. In vivo, theop/op hMRP8bcl-2mice show signifi- model (Curry and Trentin, 1967; Metcalf, 1985), M-CSF
cant replenishment of tissue macrophages. Their long drives differentiation of monocytes into tissue macro-
bone osteopetrosis is largely reversed, and extensive phages, thereby directing monocyte commitment. In an
medullary hematopoiesis appears in the bone marrow. adaptation of the stochastic model (Till and McCulloch,
We propose that M-CSF augments monocyte survival, 1963; Korn et al., 1973; Nakahata et al., 1982), M-CSF
permitting them to respond to internal and external provides a survival signal to the differentiating mono-
cues for their differentiation. cytes, and surviving cells utilize an intrinsic develop-
mental program to become mature macrophages. To
distinguish between these two models, we crossedIntroduction
hMRP8bcl-2 transgenic mice, which express Bcl-2 in
the myeloid lineage (and as a result, block programmedThe mechanisms involved in monocyte homeostasis are
cell death of monocytes), with op/op mice, which arepoorly understood. Monocytes originate in the bone
defective in M-CSF expression. We have found that sup-marrow (Volkman A., 1963; van Furth and Cohn, 1968)
pression of monocyte apoptosis in serum-free and cyto-from hematopoietic stem cells (Tilland McCulloch, 1961;
kine-free medium in vitro is sufficient to allow completeBalner, 1963; Siminovitch et al., 1963; Wu et al., 1967;
macrophage differentiation. Furthermore, we show thatSpangrude et al., 1988). Bone marrow monocytes move
Bcl-2 overexpression in monocytes rescues diverserapidly to the blood where they circulate with an average
macrophage populations in vivo, indicating that mono-transit time of 25 hours under normal steady-state con-
cytes possess an intrinsic program to differentiate to-ditions (van Furth and Cohn, 1968). After migrating into
ward macrophages in the absence of M-CSF. Comparedtissues, monocytes undergo maturation into morpho-
to the op/op mice, the op/op hMRP8bcl-2 mice have alogically, histochemically, and functionally distinct mac-
less severe form of osteopetrosis.rophage populations (Hume et al., 1983; van Furth et
al., 1985). How the circulating monocyte population is
controlled is of fundamental significance, because it is Results
from this population that tissue macrophages will de-
velop. hMRP8bcl-2 Transgenic Mice
hMRP8bcl-2 transgenic mice have been generated asThe macrophage colony-stimulating factor (M-CSF,
also called CSF-1) plays an essential role in the survival, described previously (Lagasse and Weissman, 1994).
To assess transgenic expression of Bcl-2 in monocytes,proliferation, differentiation, and/or maturation of the
mononuclear phagocyte lineage (Stanley et al., 1976, blood cells were stained with Gr-1 and Mac-1 antibodies
(Lagasse and Weissman, 1996) and then stained for1983; Guilbert and Stanley, 1980; Tushinski et al., 1982).
Injection of M-CSF into animals increases the numbers human Bcl-2 (hBcl-2) (Figure 1A). Two transgenic lines
were used in this study, hMRP8bcl-2/1, which ex-of monocytes in peripheral blood (Hume et al., 1988),
whereas no changes are observed in the number of pressed low levels of transgenic Bcl-2, and hMRP8bcl-
2/2, which expressed around 10-fold more hBcl-2. Hu-other myeloid cells. Colonies formed when bone marrow
cells are cultured in the presence of M-CSF alone con- man Bcl-2 was detected in monocytes and neutrophils,
but no expression of hBcl-2 could be detected in tissuetain predominantly monocytic cells (Koike et al., 1986;
Metcalf, 1991). Developmental regulation of M-CSF re- macrophages (Figure 1B). This distribution reflects the
fact that MRP8 protein is present in monocytes andceptor expression is the predominant mechanism for
M-CSF selectivity among hematopoietic cells (Byrne et neutrophils but not in macrophages (Lagasse and
Weissman, 1992). There was no difference in the amountal., 1981; Olweus et al., 1996). M-CSF specificity for
monocytic cells and not granulocytic cells seems to be of hBcl-2 in neutrophils versus monocytes (Figure 1A).
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Figure 1. Transgenic Expression of Human
Bcl-2 in Monocytes, Neutrophils, and Macro-
phages
(A) Peripheral blood cells from hMRP8bcl-2
mice and control littermates were stained for
Gr-1, Mac-1, and hBcl-2. Neutrophils (Gr-1hi-
Mac-1hi cells) and monocytes (Gr-1loMac-1hi
cells) were gated (boxes), and immunofluo-
rescence profiles of human Bcl-2 in these
populations were displayed as histograms.
Each histogram panel has a peak on the left
side that represents the nonspecific staining
of peripheral blood cells with control anti-
bodies.
(B) Immunostaining of spleen and bone mar-
row cells and liver sections from hMRP8bcl-2
and op/op hMRP8bcl-2 mice. Spleen and
bone marrow cells were prepared using cy-
tospin. Staining with FITC-labeled anti-
human Bcl-2 and PE-labeled anti-F4/80 re-
vealed no expression of transgenic bcl-2 in
spleen, bone marrow, and liver macrophages.
In humans, however, monocytes normally express low die rapidly in culture when deprived of exogenous
growth factors (Mangan and Wahl, 1991; Munn et al.,levels of Bcl-2, while neutrophils do not (Iwai et al., 1994).
1995). Monocytes from all genotypes were cultured on
coverslips in RPMI with or without fetal calf serum sup-Generation of op/op hMRP8bcl-2 Mice
op/1 hMRP8bcl-2/1 and op/1 hMRP8bcl-2/2 mice were plemented with L media, which is a medium rich in
M-CSF (Stanley et al., 1976; Stanley and Heard, 1977).bred with op/op and op/1 mice. The status of theM-CSF
gene in these animals was determined by PCR analysis After 24 hours in culture with no serum, only a few of
the control and op/op monocytes survived. hMRP8bcl-(see Experimental Procedures for details) using a modi-
fied method developed previously (Lieschke etal., 1994). 2/1 monocytes demonstrate a slight increase in survival
(p , 0.05), whereas most of the hMRP8bcl-2/2 and op/Transgenic mice were identified by screening for human
Bcl-2 expression in blood cells using flow cytometry. op hMRP8bcl-2/2 monocytes were viable (Figure 2A).
In contrast, after 24 hours in culture with serum and LThe screening of toothless mice revealed both op/op
and op/op hMRP8bcl-2 genotypes. No major changes media, monocytes from all genotypes survived. At 96
hours, when no adherent cells could be detected inin the appearance was observed for both op/op and
op/op hMRP8bcl-2 mice. These mice were significantly the control and op/op cultures that were incubated
in the absence of serum, most of the adherent cells fromsmaller and had reduced survival compared to wild-type
mice, presumably because the toothless state contrib- the hMRP8bcl-2/2 transgenic mice remained viable,
whereas very few of the hMRP8bcl-2/1 adherent cellsuted mainly to difficulties with nutrition.
survived (not shown). The persisting cells were large,
had the morphology of mature macrophages (FigureEnforced Expression of hBcl-2 in Monocytes
from Wild-Type or op/op Mice Allows 2D), and expressed the macrophage marker F4/80 (Fig-
ure 2C) and Mac-1 (not shown). Thus, in these experi-their Survival and Maturation
to Macrophages In Vitro ments, monocyte differentiation occurred spontane-
ously in vitro in the absence of growth factors when cellMonocytes were evaluated for cell survival in the pres-
ence or absence of growth factors (Figure 2). Monocytes viability is sustained by ectopic expression of Bcl-2. The
Bcl-2 Expression Rescues Macrophages in op/op Mice
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Figure 2. Monocyte and Macrophage Survival In Vitro
(A) Blood monocyte viability after 24 hours in culture in the presence or absence of growth factors (Serum and L media).
(B) Bone marrow macrophage viability after 24 hours in the absence of growth factors. For (A) and (B), the results are presented as a percentage
of total viable cells from the 4 hours time point in culture. The data shown are arithmetic means 6 SD, and are compiled from groups of 3±5
mice. Statistical comparisons between control and the different genetic constitutions were done using the student's t test. Only the significant
values (p , 0.05) are reported.
(C) F4/80 staining of macrophages derived from monocytes 96 hours in cultures without serum and L media.
(D) Morphology of monocytes 4 hours in culture and the derived macrophages 96 hours in culture with (1) or without (2) serum and L media.
Cells were stained by Giemsa and May-GruÈ nwald stains.
(E) Viability of mixed monocyte populations. The data shown are arithmetic means 6 SD.
survival of monocytes was more striking in cells from green fluorescent cell marker, and scored the ratio of
viable green (control) to red (hMRP8bcl-2/2) cells adher-mice that had high levels of expression of human Bcl-2
(hMRP8bcl-2/2). Even in the presence of serum and L ent to the plastic at 4 and 24 hours. If the hMRP8bcl-
2/2 blood cells produced factors that favor the survivalmedia, hMRP8bcl-2/2 monocytes survived better than
control monocytes (p , 0.03). In contrast to monocytes, of adherent monocytic cells, then the ratio of green/
red cells should remain constant. Instead, as shown inbone marrow macrophages isolated from all the differ-
ent genotypes and cultured for a week in the presence Figure 3E, the initially more numerous green controlcells
were 71.4% 6 1.6% of adherent viable cells at 4 hours.of growth factors failed toexhibit any survival advantage
when growth factors were withdrawn (Figure 2B), re- However, by 24 hours, the vast majority of green control
cells had disappeared (only 22.9% 6 13.2% of adherentflecting the absence of transgenic Bcl-2 expression in
tissue macrophages (Figure 1B). viable cells were green control cells), and the majority
of the surviving adherent monocyte/macrophages wasIt remained possible that monocyte-containing whole
blood cell (WBC) cultures from hMRP8bcl-2 mice could derived from the (initially less numerous) hMRP8bcl-2/2
donor strain.elaborate factors other than M-CSF that permit survival
of monocytes and their differentiation to macrophages;
such cells could be absent from WBC cultures from Enforced Expression of hBcl-2 in Myelomonocytic
Cells Partially Reverses Bone Pathologycontrol mice. To test this possibility critically, we mixed
hMRP8bcl-2/2 WBCs at 5 3 105 cells/ml that were in op/op Mice
Osteopetrotic op/op mice have severe deficiencies instained with PKH26 red fluorescent cell marker together
with 5 3 106 WBCs/ml of control cells stained with PKH2 bone marrow cellularity (Wiktor-Jedrzejczak et al., 1982).
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Histological examination of bone and bone marrow of 0.01), hMRP8bcl-2/1 mice, and op/op hMRP8bcl-2/1
mice.op/op hMRP8bcl-2 revealed a marked decrease in the
pathology of osteopetrotic bones, when compared to
their op/op littermates. The marrow space in 3-week- Bcl-2 Rescue of the Macrophage Population
in op/op Miceold op/op hMRP8bcl-2 femurs contained abundant he-
matopoietic cellularity which, although not as extensive The level of macrophage deficiency in the op/op mouse
varies in different tissues. Macrophages in the boneas that of femurs from control mice, clearly was more
abundant than in the op/op femurs (data not shown). In marrow and in the peritoneal and pleural cavities are
the most affected (Wiktor-Jedrzejczak et al., 1982; Cec-mice over 6 months old, the marrow cellularity of op/op
hMRP8bcl-2/2 mice was greatly increased compared to chini et al., 1994). Macrophages from the liver (Kupffer
cells) and spleen are affected to a lesser degree. Inop/op littermates, and was essentially indistinguishable
from control bone marrow (Figure 3A). In addition, op/op addition, tissue macrophages are restored incompletely
by 9±12 months of age (Cecchini et al., 1994). CellshMRP8bcl-2/1 mice had clearly more bone spicules and
demonstrated an intermediate stage of bone resorption. from bone marrow, spleen and peritoneal cavities were
isolated from 3-week-old op/op hMRP8bcl-2, op/op,Although normal mice lack bony trabeculae in the mar-
row proper, op/op hMRP8bcl-2 bones more resembled hMRP8bcl-2 mice, and control littermates. Single cell
suspensions were incubated with a panel of antibodies:human marrow with prominent spicules; thus, bone re-
sorption is probably incomplete. Mac-1 and Gr-1 to distinguish monocytes from neutro-
phils (Lagasse and Weissman, 1996), and F4/80, a pan
macrophage marker (Hume et al., 1983), to identify tis-Hematological Analysis of op/op hMRP8bcl-2
In peripheral blood, the total white blood cell count was sue macrophages. Flow cytometry and/or immunostain-
ing of frozen sections were performed to detect thenormal in all mice analyzed. Yet op/op mice show a
slight decrease in the number of circulating monocytes, relative number of neutrophils, monocytes, and macro-
phages in these different tissues. As shown in Table 1as has been previously reported elsewhere (Wiktor-
Jedrzejczak et al., 1982; Lieschke et al., 1994). In addi- and Figures 3B and 3C, expression of hBcl-2 in mono-
cytes promotes the development of multiple macro-tion, we often found an increased number of circulating
neutrophils in op/op mice compared to control mice phage subsets in op/op mice.
The number of bone marrow cells obtained from the(Table 1). The monocyte count of op/op hMRP8bcl-2/2
mice was equivalent to hMRP8bcl-2/2 mice and was long bones of 3-week-old op/op hMRP8bcl-2/2 mice
was 1.8 6 0.5 3 107 cells, which was a 10-fold increasesignificantly elevated compared to control mice (p ,
Figure 3. Bcl-2 Rescue of the Macrophage
Populations in op/op Mice
(A) Longitudinal section of the femur of 6
month old from control, hMRP8bcl-2, op/op,
op/op hMRP8bcl-2 littermates. A marked de-
crease in the severity of osteopetrotic bones
is shown in the femoral bone cavity of the
op/op hMRP8bcl-2 mice.
(B) Immunostaining of liver sections from con-
trol, hMRP8bcl-2, op/op, op/op hMRP8bcl-2
littermates. Tissue sections were stained with
PE-conjugated F4/80 antibody.
(C) FACS analysis of peritoneal cells from con-
trol, hMRP8bcl-2, op/op, op/op hMRP8bcl-2
littermates. Cells were collected from perito-
neal cavities. The histograms show F4/80
staining versus cell numbers. The number in
each plot indicates the percentage of F4/80hi
peritoneal macrophages.
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Table 1. Quantitation of Myelomonocytic Cells in Blood, Spleen, and Bone Marrow of Mice with Different Genetic Constitutions
Tissues Macrophages Monocytes Neutrophils
Blood
Control - 4.6 6 2.5 17.6 6 7.3
hMRP8bcl-2/1 - 4.3 6 0.5 (p , 0.006) 17.0 6 6.0
hMRP8bcl-2/2 - 18.3 6 3.7 4.6 6 0.5 (p , 0.03)
op/op - 3.3 6 1.1 30.0 6 17.0
op/op hMRP8bcl-2/1 - 7.0 6 1.0 26.3 6 6.3
op/op hMRP8bcl-2/2 - 22.6 6 6.8 (p , 0.01) 21.0 6 7.2
Bone marrow
Control 5.1 6 1.4 2.2 6 0.4 33.9 6 2.9
hMRP8bcl-2/1 5.0 6 0.9 2.0 6 0.3 33.6 6 2.3
hMRP8bcl-2/2 9.6 6 1.3 (p , 0.009) 12.9 6 6.9 (p , 0.05) 36.5 6 5.9
op/op 0.6 6 0.5 (p , 0.002) 0.9 6 0.3 (p , 0.015) 69.2 6 1.7 (p , 0.00005)
op/op hMRP8bcl-2/1 4.3 6 1.7 1.4 6 0.6 52.3 6 1.5 (p , 0.0006)
op/op hMRP8bcl-2/2 6.9 6 2.4 13.6 6 2.1 (p , 0.0008) 50.0 6 4.2 (p , 0.005)
Spleen
Control 2.7 6 0.8 4.0 6 0.3 2.6 6 0.9
hMRP8bcl-2/1 3.4 6 1.1 4.9 6 1.3 2.8 6 0.7
hMRP8bcl-2/2 6.9 6 3.1 (p , 0.04) 13.7 6 5.8 (p , 0.04) 22.0 6 13.3 (p , 0.05)
op/op 0.6 6 0.1 (p , 0.005) 2.3 6 0.9 (p , 0.02) 14.1 6 12.6
op/op hMRP8bcl-2/1 4.6 6 1.9 5.6 6 2.0 7.9 6 2.1 (p , 0.01)
op/op hMRP8bcl-2/2 9.2 6 2.3 (p , 0.002) 12.9 6 1.8 (p , 0.001) 20.3 6 6.3 (p , 0.008)
Mice were analyzed at 3±6 weeks of age. Data are shown as arithmetic means with standard deviations, and are compiled from groups of
3±5 mice. Statistical comparisons between control and the different genetic constitutions were done using the student's t test. Only the
significant values (p , 0.05) are reported.
over the op/op littermates (0.15 6 0.01 3 107 cells). This antigen expression from peritoneal cells revealed exten-
sive restoration of both macrophage populations fromnumber is similar to the number of cells found in control
bone marrow (3.7 6 0.8 3 107 cells). Gr-1/Mac-1 staining op/op hMRP8bcl-2 mice (Figure 3C). Finally, Kupffer
cells were analyzed in the liver by immunostaining withof the cells revealed monocytosis (Gr-1loMac-1hi cells)
in op/op hMRP8bcl-2/2 mice, when compared to control F4/80 antibodies. As shown in Figure 3B, F4/80-positive
Kupffer cells are abnormally low in op/op liver. In con-mice (Table 1). The monocytosis was remarkably similar
to that in hMRP8bcl-2/2 mice and may explain the in- trast, the density of Kupffer cells was normal in op/op
hMRP8bcl-2/2 and was at intermediate levels in op/opcrease of blood monocytes shown in Table 1. Macro-
phages (F4/80hi cells) were also detected in op/op hMRP8bcl-2/1 liver when compared with control and
hMRP8bcl-2 mice.hMRP8bcl-2/2 bone marrow at a level equivalent to con-
trol bone marrow; this reflected a net increase in bone
marrow macrophages compared to op/op mice. The Cell Proliferation Analysis of White Cells Reveals
a Long-Lived Bone Marrow Monocyteop/op hMRP8bcl-2/1 mice had only a slight increase in
the number of bone marrow cells (0.3 6 0.1 3 107 cells), Population in hMRP8bcl-2/2 Mice
The population of nondividing blood monocytes isindicating a limited rescue of bone marrow, as illustrated
in Figure 3A. We found evidence of splenomegaly with derived from dividing myelomonocytic precursors in
hematopoietic tissues (Balner, 1963; van Furth andextramedullary hematopoiesis in op/op and op/op
hMRP8bcl-2 of all ages. Flow cytometric analysis of Cohn, 1968). In control mice, bone marrow myelopoiesis
predominates over spleen myelopoiesis ([van Furth andspleen cells from 3-week-old mice revealed an expan-
sion in the myeloid cell compartment, characterized by Cohn, 1968; Volkman A., 1963] and Table 1). hMRP8bcl-
2/1 mice are much like control mice in terms of mono-an increase in neutrophils and monocytes (Table 1). F4/
80hi splenic macrophage numbers were increased; this cyte numbers in bone marrow, blood, and spleen (Table
1), but MRP8bcl-2/2 mice have a relative monocyto-was confirmed in mice by immunostaining of frozen sec-
tions with F4/80 and Mac-1 monoclonal antibodies (not sis in blood, bone marrow, and spleen, and their spleens
are actively engaged in hematopoiesis (Lagasse andshown). Peritoneal and pleural macrophages are defi-
cient in young op/op mice. We tested whether Bcl-2 Weissman, unpublished data). If the bone marrow in
hMRP8bcl-2/2 mice contained a significant componentexpression in monocytes could promote maturation of
peritoneal macrophages in3-week-old op/opmice. Peri- of long-lived monocytes, one might expect that this pop-
ulation would not incorporate 5-bromo-29-deoxyuridinetoneal cells were isolated from untreated mice. Approxi-
mately 2- to 5-fold fewer cells were recovered from (BrdU) into its DNA. To test this hypothesis, mice were
injected with BrdU at time 0 and at 22 hours; from 0±22op/op hMRP8bcl-2 mice (with a wide variation due to
the inherent difficulties of isolation of peritoneal cells) hours, the mice were also allowed to drink water con-
taining BrdU, as described previously (van Furth andwhen compared to control or hMRP8bcl-2 littermates.
At least 10-fold fewer cells were isolated from op/op van Zwet, 1988). After BrdU was removed, at 8, 24, and
96 hours, the fraction of monocytes in blood, spleen,peritoneal cavities, indicating the scarcity of these cells
in these mice. Flow cytometric analysis of F4/80 surface and bone marrow that had gone through at least one S
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were not measurably in cycle and were not contami-Table 2. Relative Persistence of hMRP8bcl-2/2 Cells versus
Control Blood Monocytes 96 Hours after Intravenous nated with proliferating monocyte precursors. Blood
Injection monocytes in hMRP8bcl-2 mice as well as control mice
are G0/G1 cells with 2n amounts of DNA (not shown).Blood Spleen Bone Marrow
WBCs containing G0/G1 monocytes from hMRP8bcl-
Control (Ly5.1) 1.53 6 0.44 0.84 6 0.22 3.74 6 1.19
2/2 Ly5.2 mice were mixed with WBCs from controlhMRP8bcl-2/2 (Ly5.2) 34.33 6 21.6 11.89 6 3.50 30.1 6 5.49
Ly5.1 donors, and the mixture was injected into con-
Control whole blood cells (1.5 3 108) from Ly5.1 donors were mixed genic (Ly5.1 3 Ly5.2)F1 hosts. To normalize the injec-
with 4 3 106 hMRP8bcl-2 Ly5.2 donor WBCs and injected into tions, 1.5 3 108 Ly5.1 WBCs containing 7.5±8 3 106
(Ly5.1 3 Ly5.2)F1 hosts. Equivalent numbers of monocytes were
monocytes were mixed with 4 3 107 Ly5.2 WBCs, alsoinjected (2.5-8 3 106 cells). Whereas 5% of the Ly5.1 WBCs were
containing 7.5±8 3 106 monocytes. Four days followingmonocytes, 20% of the hMRP8bcl-2/2 WBCs were monocytes. Four
days later, blood, spleen, and bone marrow were harvested and IV injection of this mixture, the (Ly5.1 3 Ly5.2)F1 hosts
stained with antibodies specific for Ly5.1, Ly5.2, Gr-1, and Mac-1. were sacrificed, and the percentage of white cells of
The percentage of surviving WBCs from either Ly5.1 (control) or either Ly5.1 or Ly5.2 origin that are monocytes was
Ly5.2 (hMRP8bcl-2/2) donors that are monocytes is presented. Data counted. As expected from the BrdU labeling experi-
shown are arithmetic means with standard deviations, and are from
ments, most white blood cells are in rapid transit from3 mice.
blood to tissues, and so the vast majority of injected
cells have left the blood. While most Ly5.1 control white
blood cells that persist are not monocytes (0.8%±3.7%phase was assessedby staining with anti-BrdU antibod-
of control donor cells are monocytes), the relative per-ies, as described (Carayon and Bord, 1992). By 8 hours,
sistence of Ly5.2 monocytes (as a percentage of Ly5.287.3% 6 11.3% of bone marrow monocytes from control
donor whitecells) ranges from 12%±34%(Table 2). Thus,and 81.9% 6 15.2% from hMRP8bcl-2/1 mice had la-
nondividing hMRP8bcl-2/2 monocytes remain as mono-beled (Figure 4), while only 54.0% 6 2.4% of bone mar-
cytes in blood, bone marrow, and spleen to a greaterrow monocytes from hMRP8bcl-2/2 mice were labeled.
degree than do nondividing monocytes from controlThis indicates the presence of a large pool of nondivid-
Ly5.1 donors. In addition, purified blood monocytesing, longer-lived monocytes in the bone marrow of these
sorted from control or hMRP8bcl-2/2 mice were labeledhMRP8bcl-2/2 mice that are less frequent in control and
in vitro with 51Cr and injected IV to determine the resi-hMRP8bcl-2/1 mice. This difference persists throughout
dence time of these cells in the blood and their homingthe experimental interval of 8±96 hours post BrdU re-
to tissues. Greater than 98% of injected labeled cellsmoval. This difference is not present in blood. We inter-
were gone from blood by 4 hours, and as expected, thepret this result to mean that newly produced bone mar-
label was retained in lung, liver, and spleen (data notrow monocytes either migrate to blood or die in normal
shown), as previously described for other labeled leuko-mice, and that the nonmigrants in hMRP8bcl-2/2 bone
cyte populations (Gutman and Weissman, 1973; Butchermarrow die more slowly.
et al., 1980). Although the whole body 51Cr count retained
at 4 days was slightly but significantly higher (student'shMRP8bcl-2/2 Monocytes Survive Preferentially
t test, p , 0.038 with 4 mice per group) in hMRP8bcl-upon Injection into Normal Hosts
2/2 injected hosts, it was not determined in this experi-The expression of hBcl-2 in myelomonocytic cells could
ment if the retained label was present in live progenyenhance monocyte survival and/or cause monocytes to
of injected cells.proliferate in vivo. The BrdU incorporation studies
shown above provide evidence that hMRP8bcl-2/2
A High Proportion of hMRP8bcl-2/2 Splenic Myeloidmonocyte precursors that can enter the blood are prolif-
Cells Can Differentiate to Hepatic Kupffererating at about the same rate as those in hMRP8bcl-
Cells Following Intravenous Injections2/1 or control mice. To test survival of monocytes inde-
In the previous sections, a significant fraction of input-pendent of proliferation, we obtained monocytes that
labeled or marked monocytes was found to localize to
liver, spleen, and lungs. To test whether the liver label
reflected dead or differentiated cells, and to test the
potential role of expressed hMRP8bcl-2/2 on these out-
comes, 8 3 107 PKH26 red±labeled hMRP8bcl-2/2
spleen cells mixed with 5 3 108 green control spleno-
cytes were injected into control or op/op hosts. Their
spleens and livers were obtained for microscopic analy-
sis 96 hours later (Figure 5). Approximately equal num-
bers of hMRP8bcl-2/2 and control monocytes (107
monocytes) were contained in the inoculum (1:1 red/
green monocytes). By 96 hours, the ratio of red/green
cells in the liver was over 50:1 (Figure 5D), whether the
hosts were controls or op/op mice. The hMRP8bcl-2/2
cells in these livers were virtually all Kupffer cells (FigureFigure 4. Measurement of Monocytes Turnover with BrdU
5B), while very few control cells (dyed green) could bePercentage of BrdU-positive monocytes in blood and bone marrow
detected as cells in the liver. Labeled cells did not ap-from control, hMRP8bcl-2/1 and hMRP8bcl-2/2 mice. Each point
represents the average 6 SD from three mice. pear patchy or spotted, and the fluorescent dye was
Bcl-2 Expression Rescues Macrophages in op/op Mice
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Figure 5. Fate of Control and hMRP8bcl-2
Spleen Populations after IV Injections
Two groups of mice, control (n 5 2) and op/
op (n 5 2), were injected with spleen cell pop-
ulations from control and hMRP8bcl-2/2
mice. (A) hMRP8bcl-2/2 cells stained with
PKH26 red dye and control cells stained with
PKH2 green dye were mixed 1:10, respec-
tively. (B) Liver section of an op/op mouse,
96 hours after injection. A high proportion of
hMRP8bcl-2/2 splenic myeloid cells can dif-
ferentiate into hepatic Kupffer cells.
(C) Spleen section of an op/op mouse, 96
hours after injection.
(D) Absolute cell count per microscopic
field 6 SD.
not localized in the phagocytic compartments of the hematopoietic differentiation (Fairbairn et al., 1993; Wu
cells. By 51Cr label studies, at this time point 40% of the et al., 1995; Silva et al., 1996). It is possible, of course,
whole body label was retained in the liver. We interpret that Bcl-2 can both block apoptosis and play a role
these data as evidence that hMRP8bcl-2/2 myelomono- in cell differentiation (Fernandez-Sarabia and Bischoff,
cytic cells survive and are permitted to differentiate to 1993; Wang et al., 1994). That possibility cannot be ruled
Kupffer cells in an M-CSF-independent manner, while out until the downstream pathways set in motion by
control origin cells that home to the liver die or were Bcl-2 are completely understood.
dead, and their 51Cr-labeled protein, but not the fluores- The exact in vivo functions of M-CSF has been difficult
cent-labeled membrane lipids, is retained in the liver. to define. The osteopetrotic (op/op) mutant mouse is
The viability and homing of other splenic populations devoid of M-CSF and is characterized by a generalized
were excellent from both hMRP8bcl-2/2 and control do- macrophage and osteoclast deficiency (Marks and
nors, as shown by their roughly equal contribution to Lane, 1976; Wiktor-Jedrzejczak et al., 1982; Marks,
the host splenocyte pool. 1984). Implantation of diffusion chambers containing
M-CSF-secreting L-929 cells in the peritoneal cavity of
Discussion op/op mice partially corrected the macrophage defi-
ciency (Wiktor-Jedrzejczak et al., 1990). Injection of re-
Several studies have demonstrated that M-CSF is an combinant M-CSF restored the development of macro-
essential cytokine for the differentiation of myelomono- phages and osteoclasts in these mice (Felix et al., 1990;
cytic progenitors into macrophages (Metcalf, 1970; Kodama et al., 1991; Wiktor-Jedrzejczak et al., 1991).
Stanley, 1981). Because growth factors can be required Injection of GM-CSF corrects the macrophage defi-
for hematopoietic cell survival (Vaux et al., 1988), it is ciency also, but not the osteopetrosis that results from
unclear whether M-CSF is necessary for differentiation a lack of osteoclast-mediated remodeling of bones (Wik-
of monocytes into macrophages, or survival of mono- tor-Jedrzejczak et al., 1994). Interestingly, GM-CSF also
cytes to the stage at which they respond to intrinsic or corrects pleural and peritoneal macrophage deficien-
extrinsic stimuli to become macrophages, or both. In
cies that were not corrected by similarly administered
these studies, monocytes that overexpress the bcl-2
M-CSF, which required local administration for correc-
transgene remain viable in the absence of M-CSF, while
tion. Here, we show that rescuing monocytes from pro-
their wild-type and op/opcounterparts die by apoptosis.
grammed cell death using an intrinsic factor, the proto-In the in vitro cultures of monocytes in the absence of
oncogene bcl-2, is capable of correcting macrophageserum or M-CSF described here, the monocytes can
deficiencies in op/op mice in a way similar to extrinsicundergo macrophage differentiation, indicating that
factors, such as M-CSF and GM-CSF. Although the re-expression of levels of Bcl-2 that block monocyte
stored macrophage populations in peritoneal cavities inapoptosis are sufficient for macrophage maturation.
op/op hMRP8bcl-2 mice were quantitatively fewer thanThese studies suggest a model whereby M-CSF is not
in wild-type mice, it clearly indicates that unless pro-required for the induction of monocyte differentiation,
vided with tissue-specific survival signals, monocytesbut rather promotes differentiation by providing survival
undergo spontaneous apoptosis within or upon leavingsignals, a function that is essential for maturation of
the circulation. Overexpression of Bcl-2 in the myelo-macrophages. This model is consistent with previous
monocytic lineage and blockade of monocyte cell deathstudies where maintained viability in different estab-
had an incomplete rescue of osteopetrotic lesions: teethlished in vitro hematopoietic cell lines conferred by ex-
pressing anti-apoptotic genes can indirectly result in did not erupt and bone remodeling to form the medullary
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cavities was incomplete, leaving a spicular network (Fig- model predicts that during normal macrophage produc-
tion, functional M-CSF/M-CSF receptor engagement isure 3A). We do not yet know if the failure of dental
eruption reflects a fundamentally different mechanism sufficient for only a subset of ªnaiveº monocytes to
survive and undergo maturation into morphologically,from bone medullary remodeling, a failure of hMRP8-
driven expression of Bcl-2 in monocyte precursors of histochemically, and functionally distinct macrophage
populations, depending on their microenvironments.neonatal tooth osteoclasts, a quantitative threshold
difference for tooth versus bone, or some as yet undeter- When macrophage production needs to be increased
because of inflammation or infection, M-CSF and othermined mechanism. The osteoclast is a cell that resorbs
bone and derives from hematopoietic precursors (Hage- cytokines would increase, and many of the monocytes
that would ordinarily die survive to expand into macro-naars et al., 1989; Hattersley and Chambers, 1989). The
osteoclast population shares several features with other phage populations.
We therefore propose that monocyte homeostasis iscells of the mononuclear phagocyte system (MPS); how-
ever, its precise cellular ontogeny is unknown, and its significantly regulated by apoptosis and that the princi-
pal function of M-CSF in the commitment of bloodmembership in the MPS is controversial (Lee et al., 1992;
Chambers et al., 1993; Grigoriadis et al., 1994). Our data monocytes to tissue macrophages is to permit survival
of monocytic cells, therefore maintaining a pool of theseare in agreement with the possibility that osteoclast
ontogeny is regulated differently from macrophage on- cells able to populate various macrophage compart-
ments. In this model, monocytes kept alive by the actiontogeny. Here, we propose a model for macrophage on-
togeny where survival of monocytes, the macrophage of M-CSF are able to shape the heterogeneity of the
macrophage populations through differentiation pro-progenitors, is underthe influence of M-CSF, the primary
tissue-specific regulatory molecule (Figure 6). This cesses that are provided by various cellular microenvi-
ronments. This model does not mean, of course, that the
high mitogenic potential of M-CSF is not also involved
in maintaining the macrophage compartment. M-CSF
could be mitogenic for monocyte precursors, and if so,
could be involved directly in cell-cycle regulation, or in
survival of cells that are or can proliferate, or indirectly,
through the secreted or cell-surface mitogens that can
be elaborated by cells of the myelomonocytic lineage.
MRP8 (and hMRP8bcl-2) is expressed in monocytes, in
neutrophils, and likely in an immediate precursor popu-
lation to both. Thus cell survival, cell proliferation, and
factor production by these populations could all play
a role in determining the outcomes of enforced Bcl-2
expression in these cells. It is of interest in this regard
that the hMRP8bcl-2/2 mice do have increased bone
marrow and splenic hematopoiesis (Lagasse and Weiss-
man, unpublished data). Both survival and proliferation
provide the conditions whereby multipotent and lin-
eage-restricted progenitor cells undergo differentiation
and development to produce mature cells. In general,
it is possible that other cytokines act in the same way
in preserving cells at a sensitive stage of differentiation,
allowing the surviving cells to respond to other internal
or external stimuli during maturation. In a companion
publication, we demonstrate that enforced expression
of hBcl-2 in lymphoid lineages of IL-7Ra2/2 mice largely
reverses the extensive defects in thymic and T lympho-
cyte maturation and homeostasis (but not in the B cell
lineage) of these SCID mice (Akashi et al., 1997 [this
issue of Cell]). Thus, in both T lymphopoiesis and mono-
cytopoiesis, a principal function of cytokine/cytokine
receptor interaction is the elaboration of signals that
permit cell survival.
This model is a potential example of homeostasis by
cellular competition for limiting niches where specific
cytokines would be accessible for survival and matura-
tion of precursor cells with a predetermined differen-
Figure 6. Model for Monocyte Homeostasis
tiation program. In this model, progenitor cells would
Two checkpoints for survival are present in the maturation pathway
rapidly die unless the microenvironments, as limitingof monocytes: the first, in the bone marrow at the level of new
niches, would provide survival and therefore retentionmonocytes pre-release into the bloodstream, and the second, in
of the selected cells. While circulating M-CSF levels inthe peripheral tissues post their exit from the bloodstream. See text
for details. normal mice are at sufficient concentration to stimulate
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modified method by Veis et al. (1993). After surface staining, the cellsmaximum macrophage proliferation in vitro (Tushinski
were fixed with 0.8% paraformaldehyde for 5 min at 48C. The cellset al., 1982), it is not yet known what the concentrations
were washed and permeabilized with 0.3% saponin containing anti-might be in specialized tissue niches. Obviously, it will
human Bcl-2 MAb (FITC, clone 124, Dako) overnight. Cells were
be important to define cells and niches that are involved washed and resuspended in PBS containing 0.03% saponin prior
in the checkpoints of promonocyte → monocyte and to FACS analysis. FACS analysis was performed with FACS desk
software (Beckman Center Shared FACS Facility).monocyte → macrophage lineage maturation, and to
determine the availability of M-CSF and the relative frac-
Tissue Sectiontion of M-CSF receptor containing M-CSF in these mi-
For immunofluorescence, cryostat sections (5 mm) were fixed andcroenvironments. Nevertheless, these features resem-
stained as previously described (Lagasse and Weissman, 1992).ble the cellular competition for restricted survival signals
Sections were incubated for an hour with F4/80-PE or Mac-1-PE
that is well characterized in the nervous system (Oppen- monoclonal antibodies. For bone sections, femurs were decalcified
heim, 1991) as well as the cellular competition for follicu- before mounting andsectioning. The formalin-fixed paraffin-embed-
lar niches in B cell development (Cyster et al., 1994), ded sections of bone were stained using standard techniques with
hematoxylin and eosin.and has been postulated to be a general mechanism
for controlling bothcell number and location (Raff, 1992).
BrdU Labeling
BrdU (Sigma) was administered 24 hours starting by an intraperito-Experimental Procedures
neal injection of saline solution containing BrdU (0.8 mg/mouse).
BrdU was added in the drinking water at a concentration of 0.8 mg/Mice
ml with 5% glucose to overcome taste aversion. At 22 hours, aop/op hMRP8bcl-2 transgenic mice were generated by initial breed-
second dose of BrdU was administered intraperitoneally and regularing of hMRP8bcl-2 transgenic mice (C57Bl/Thy1.1) (Lagasse and
drinking water was added. The free BrdU is cleared by 1±2 hr afterWeissman, 1994) with op/1 mice (M-CSF2/1 or CSF-12/1) obtained
injection, giving 24 hr of BrdU incorporation. To detect BrdU infrom Jackson Laboratories (Bar Harbor, Maine), followed by op/1
monocytes, cells were first stained with directly labeled antibodieshMRP8bcl-2 mice with op/1 mice interbreeding. All mice presented
(Biotinylated-Gr-1, APC-conjugated Mac-1, and PE-conjugated F4/in this analysis have been backcrossed to the transgenic strain for
80 [Caltag]), fixed in Tween 20±containing paraformaldehyde fol-more than 3 generations and were homozygous for Thy1.1. Mice
lowed by bovine pancreatic DNAse I treatment as described pre-were bred and maintained at Stanford University Medical School,
viously (Carayon and Bord, 1992). The cells were then stained withand their care was in accordance with Stanford guidelines. Tooth-
fluoresceinated anti-BrdU monoclonal antibody (Beckton-Dickin-less mice were fed with powdered mouse food.
son) and streptavidin-Texas red. Analysis was performed on Van-
tage (Beckton-Dickinson) and gated for Gr-1lo/Mac-1hi/F4/80lo mono-
PCR Analysis for Diagnosis of op Allelic Status cytes.
The genotype of mice was determined by PCR analysis according
to the modified method published previously (Lieschke et al., 1994).
Cell LabelingIn brief, PCR reactions (10 ml) containing 100 ng of tail DNA, 50 mM
Blood and spleen cells were labeled with PKH2-GL and PKH26-GLKCl, 10 mM Tris (pH 8.3), 1.5 mM MgCl2, 0.1% gelatin w/v, 200 mM
(Sigma) using in vitro labeling methods described by the manufac-dNTP, 12.5 ng of primers, 1 U of Taq polymerase, and 10 mCi of [a-35S]
ture. Labeled blood cells were cultured as described for the viabilitydATP (Amersham Life Science) were incubated at 968C for 1 min,
assay. Labeled spleen cells were injected IV 96 hr later, mice were558C for 2 min, and 728C for 2 min for 30 cycles. The PCR reaction
sacrified, and spleen and liver were embedded in O. C. T. (Tissue-generated radiolabeled DNA fragments of 195 bp or 196 bp, de-
Tek). Cryostat section (10 mm) were analyzed under fluorescentpending on the op mutation. In addition, the 2-bp mismatch in one
microscope (Nikon) using a dual Texas Red/FITC filter.of the primers introduced a second BglI site for the op mutation.
PCR products digested with BglI in a total volume of 20 ml, generated
Acknowledgmentsthree different patterns, depending on the genotype of the mouse.
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